5F3J image
Deposition Date 2015-12-02
Release Date 2016-05-18
Last Version Date 2024-11-13
Entry Detail
PDB ID:
5F3J
Keywords:
Title:
Crystal structure of DBP in complex with inhibitory monoclonal antibody 2D10
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
4.00 Å
R-Value Free:
0.29
R-Value Work:
0.26
R-Value Observed:
0.26
Space Group:
P 1 21 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Duffy receptor
Gene (Uniprot):PVDR
Chain IDs:A, B
Chain Length:317
Number of Molecules:2
Biological Source:Plasmodium vivax (strain Salvador I)
Polymer Type:polypeptide(L)
Molecule:Antibody 2D10 single chain variable fragment
Chain IDs:C, D
Chain Length:305
Number of Molecules:2
Biological Source:Mus musculus
Ligand Molecules
Primary Citation
Broadly neutralizing epitopes in the Plasmodium vivax vaccine candidate Duffy Binding Protein.
Proc.Natl.Acad.Sci.USA 113 6277 6282 (2016)
PMID: 27194724 DOI: 10.1073/pnas.1600488113

Abstact

Plasmodium vivax Duffy Binding Protein (PvDBP) is the most promising vaccine candidate for P. vivax malaria. The polymorphic nature of PvDBP induces strain-specific immune responses, however, and the epitopes of broadly neutralizing antibodies are unknown. These features hamper the rational design of potent DBP-based vaccines and necessitate the identification of globally conserved epitopes. Using X-ray crystallography, small-angle X-ray scattering, hydrogen-deuterium exchange mass spectrometry, and mutational mapping, we have defined epitopes for three inhibitory mAbs (mAbs 2D10, 2H2, and 2C6) and one noninhibitory mAb (3D10) that engage DBP. These studies expand the currently known inhibitory epitope repertoire by establishing protective motifs in subdomain three outside the receptor-binding and dimerization residues of DBP, and introduce globally conserved protective targets. All of the epitopes are highly conserved among DBP alleles. The identification of broadly conserved epitopes of inhibitory antibodies provides critical motifs that should be retained in the next generation of potent vaccines for P. vivax malaria.

Legend

Protein

Chemical

Disease

Primary Citation of related structures